WASHINGTON, March 9, 2018 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) and Integrated DNA Technologies (“IDT”) announced today that Danaher has entered into a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics. IDT’s primary... Read more
WASHINGTON, Jan. 30, 2018 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced that, effective January 1, 2019, Matthew R. McGrew, Group CFO of the Company’s Diagnostics and Dental platforms, will succeed Daniel L. Comas as Chief Financial Officer. Mr. Comas will continue as an Executive Vice President of the Company, and a member of the Office... Read more
WASHINGTON, Nov. 28, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors is appointing Joakim Weidemanis to the position of Executive Vice President of Danaher Corporation, with responsibility for the Company’s Product Identification and Water Quality platforms. With this appointment, Mr. Weidemanis will become an Executive Officer of the Company.... Read more
WASHINGTON, Aug. 31, 2017 /PRNewswire/ — Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Vertical Research Partners Industrial Conference in Westbrook, Connecticut on Thursday, September 7, 2017 at 8:45 a.m. ET. About DanaherDanaher is a global science and technology innovator committed to helping... Read more
WASHINGTON, June 20, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that its wholly-owned subsidiary, DH Europe Finance S.A. (“Danaher International”), has priced an offering of: €250 million principal amount of floating rate senior notes due 2022 at an offering price of 100.147% of the principal amount; and €600 million principal amount of... Read more
WASHINGTON, June 8, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, and Executive Vice President Rainer Blair will be presenting at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California on Wednesday, June 14, 2017 at 10:00 a.m. PT. The audio will... Read more
WASHINGTON, May 25, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bernstein Strategic Decisions Conference in New York City on Thursday, June 1, 2017 at 8:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived... Read more
WASHINGTON, May 15, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Electrical Products Group Conference in Longboat Key, Florida on Monday, May 22, 2017 at 10:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on... Read more
WASHINGTON, May 10, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on Wednesday, May 17, 2017 at 9:20 a.m. PT. The audio will be simultaneously webcast on www.danaher.com. ... Read more
SCIEX features its ground-breaking biologics solutions including the X500B QTOF System and the Fast Glycan Labeling and Analysis Kit April 11, 2017 Framingham, MA — SCIEX, a Danaher company and global leader in life science analytical technologies, today announced that it presented the company’s latest ground-breaking biologics solutions at the Danaher Life Sciences Biologics Day.... Read more